Records 1 - 5
| Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
Genes, chromosomes & cancer 2018 Aug .
Wu Shang-Gin, Liu Yi-Nan, Yu Chong-Jen, Yang James Chih-Hsin, Shih Jin-Yu
| The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients.
Oncotarget 2016 Feb .
Wu Shang-Gin, Liu Yi-Nan, Tsai Meng-Feng, Chang Yih-Leong, Yu Chong-Jen, Yang Pan-Chyr, Yang James Chih-Hsin, Wen Yueh-Feng, Shih Jin-Yu
| Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Gastroenterology 2014 Dec 147 (6): 1350-62.e4.
Liang Qiaoyi, Yao Xiaotian, Tang Senwei, Zhang Jingwan, Yau Tung On, Li Xiaoxing, Tang Ceen-Ming, Kang Wei, Lung Raymond W M, Li Jing Woei, Chan Ting Fung, Xing Rui, Lu Youyong, Lo Kwok Wai, Wong Nathalie, To Ka Fai, Yu Chang, Chan Francis K L, Sung Joseph J Y, Yu J
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71.
Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife
| AKT1 and AKT2 mutations in lung cancer in a Japanese population.
Molecular medicine reports 0 1 (5): 663-6.
Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita